WASHINGTON, Oct 12 (Reuters) - U.S. antitrust officials have approved Bristol-Myers Squibb Co’s (BMY.N: Quote, Profile, Research) purchase of Adnexus Therapeutics Inc, the Federal Trade Commission said on Friday.
WASHINGTON, Oct 12 (Reuters) - U.S. antitrust officials have approved Bristol-Myers Squibb Co’s (BMY.N: Quote, Profile, Research) purchase of Adnexus Therapeutics Inc, the Federal Trade Commission said on Friday.
